Thyroid hormone and retinoic acid induce the synthesis of insulin-like growth factor-binding protein-4 in prepubertal pig sertoli cells.
A large body of evidence suggests the existence of an intratesticular IGF system complete with ligands, receptors and binding proteins (IGFBPs); the aim of the present study was to evaluate tri-iodothyronine (T(3)) and retinoic acid (RA) effects on IGFBP production by Sertoli cells. A significant dose-dependent increase in IGFBP-4 mRNA levels was observed in Sertoli cells cultured in the presence of physiological concentrations of T(3) or RA. This response was inhibited by cycloheximide, indicating that de novo protein synthesis is required, as well as by actinomycin D, suggesting that the increase in mRNA levels requires transcriptional activation. As shown by ligand blot assays the stimulatory effects of both agents on IGFBP-4 mRNA expression appears to be consistent with an enhanced synthesis and secretion of IGFBP-4, thus suggesting that the transcriptional response is transduced to the protein level. Our data establish an important direct role for T(3) and RA in regulating IGFBP-4 expression and consequently IGF activity at the testis level.
Bardi
G
G
Dipartimento di Biologia Sperimentale, Ambientale ed Applicata, Sezione di Fisiologia Generale e Comparata, Università degli Studi di Genova, Genoa, Italy.
Bottazzi
C
C
Demori
I
I
Palmero
S
S
D000818:Animals; D015152:Blotting, Northern; D002478:Cells, Cultured; D017077:Culture Media, Conditioned; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D018974:Insulin-Like Growth Factor Binding Protein 4 / Q000096:biosynthesis* / Q000235:genetics; D008297:Male; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D012708:Sertoli Cells / Q000187:drug effects* / Q000378:metabolism*; D012741:Sexual Maturation; D013552:Swine; D014212:Tretinoin / Q000008:administration & dosage / Q000494:pharmacology*; D014284:Triiodothyronine / Q000008:administration & dosage / Q000494:pharmacology*
D017077:Culture Media, Conditioned; D018974:Insulin-Like Growth Factor Binding Protein 4; D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; D014284:Triiodothyronine; D003609:Dactinomycin; D014212:Tretinoin; D003513:Cycloheximide